Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ningbo Kangercon Pharmaceutical is a specialized pharmaceutical company based in China that focuses on the research, development, and large-scale manufacturing of active pharmaceutical ingredients (APIs) and advanced intermediates. As a key subsidiary of the Menovo Pharmaceutical Group, the company operates high-standard production facilities that comply with international GMP requirements, including those of the FDA and EDQM. Its product portfolio primarily covers therapeutic areas such as cardiovascular health, gastroenterology, and anti-infectives. In addition to its own product line, the company provides contract manufacturing (CMO) and development services to global pharmaceutical partners, leveraging its expertise in complex chemical synthesis and industrial-scale production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ningbo Kangercon Menova Pharmaceutical.